Company profile

Ruining Bio company profile

Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.

Business identity

Operating status
Active
Company type
For Profit
Founded
2018-01-01

Headquarters

Headquarters
China, Jiading, Shanghai
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$24.2M
Last funding
Series B / $8.5M / 2024-01-24
Last equity funding
Series B / $8.5M
Investors
6
Lead investors
1

Founders and investors

Lead investors

Dingxin Capital

Investors

Deshi CapitalDingxin CapitalPickup CapitalQiming Venture PartnersTaiyu Investment

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.